Advertisement

Topics

Zemplar API Insights, 2017 [Report Updated: 10072017] Prices from USD $500

07:35 EDT 9 Aug 2017 | BioPortfolio Report Blog

DelveInsight's, Zemplar API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to the Zemplar. The report also highlights the patent details of Zemplar.
The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Scope:
Evaluate the marketing status of Zemplar to exploit opportunities for generic Zemplar development opportunities
Design effective counterstrategies to gain competitive advantage by identifying the key patent expiry details with respect to Zemplar
API intelligence over Zemplar and gaining primary intelligence over Active Ingredient manufacturers by country
Make more informed business decisions from insightful and indepth analysis of the Zemplar's performance
Zemplar
Abbott Laboratories
secondary hyperparathyroidism
Zemplar Marketed Drugs Overview
Zemplar Market Assessment
Zemplar API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
Zemplar US DMF
Zemplar US Drug Master Files
Zemplar Active Substance Master File/ EUDMF
Zemplar Generic players
Zemplar Patent Expiration
Zemplar Patent Exclusivity
Zemplar API Manufacturers
Zemplar Global Forecasted Sales Figure

Original Article: Zemplar API Insights, 2017 [Report Updated: 10072017] Prices from USD $500

NEXT ARTICLE

More From BioPortfolio on "Zemplar API Insights, 2017 [Report Updated: 10072017] Prices from USD $500"

Quick Search
Advertisement
 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Abbott
The 11th largest pharmaceutical company in the world, <!--LGfEGNT2Lhm-->Abbott Laboratories generated sales of $16 billion in 2009 and has 90,000 employees. Within the <!--LGfEGNT2Lhm-->medical device arm of the company, products of note ar...